Posted by H. Sandra Chevalier-Batik
Is the HPV vaccine a victory for women’s health or the triumph of aggressive marketing?
Canadian reporters struggle to shed light on a muddled debate that’s as much about business as it is about health.
When federal Finance Minister Jim Flaherty announced $300 million in funding for a program to vaccinate girls and young women against the […]
Posted by H. Sandra Chevalier-Batik
In 1994, Congress passed the Dietary Supplement Health and Education Act (DSHEA).
The passage of DSHEA witnessed the biggest victory for consumers in the history of Congress. More letters were written to Congress than on any other piece of legislation in the history of our country. The voice of the people spoke louder on dietary […]
Posted by H. Sandra Chevalier-Batik
Industry attacks supplements to eliminate weight-loss competition.
Big Pharma is at it again, this time teaming up with other anti-supplement cohorts to spearhead a petition that urges the Food and Drug Administration (FDA) to implement stringent new limitations on manufacturers of weight-management supplements. Of course, it should come as no surprise that the particular large […]
Posted by H. Sandra Chevalier-Batik
The Food and Drug Administration should rethink its rejection of the Declaration of Helsinki.
Later this year, the US Food and Drug Administration (FDA) will adopt new standards for human clinical trials conducted without its advance sign-off in foreign countries. The rules will govern whether data from such trials can be used in applications to market […]
Posted by H. Sandra Chevalier-Batik
Drug manufacturers could be protected from side-effect lawsuits.
Synthetic drug treachery has plummeted to a new ethical low with a disturbing development that may grant Big Pharma eternal immunity from consumer lawsuits. This most recent affront to justice involves a birth-control drug with side effects believed to have caused the deaths of 40 women, along […]
Posted by H. Sandra Chevalier-Batik
Litigation process may protect our daughters from being
‘One-More’ victim to corporate greed and bad medical policy.
On June 8, 2006, the U.S. Food and Drug Administration (FDA) approved Gardasil, the first vaccine designed to prevent cervical cancer in girls and women. Gardasil, manufactured by Merck & Co., is for use in girls ages […]
Posted by H. Sandra Chevalier-Batik
The Secret History of the War on Cancer
By Devra Davis, PhD, MPH
Review by Leslie Botha, Holy Hormones Honey!
In a recent interview on CSPAN Davis stated, “For much of its history, the cancer war has been fighting the wrong battles, with the wrong weapons, against the wrong enemies.”
The Secret History of the War on Cancer by […]
By H. Sandra Chevalier-Batik
|
Also posted in Big Pharma Watch, Breast Cancer, Cancer Research, Cervical Cancer, FDA Clinical Trials, FDA Conflict of Interest, HPV Infection, HRT, PAP Test, Proactive Nutrition, Questionable Medicine, STD Infection
|
Posted by H. Sandra Chevalier-Batik
Big Pharma Giants Schering and Merck
Take Heavy Criticism Over Vytorin Failure
This week Merck executives are very grateful for the revenue predictions for their blockbuster HPV vaccine, GARDASIL. Profits are predicted to climb from $300 million to $4 billion over the next year. After the Vytorin debacle —they’re going to need the cash.
So lock up your […]
Posted by H. Sandra Chevalier-Batik
Universal Out Rage Rings Peal Over French Website Developer
When a French website called Ma-Bimbo quickly boasts 1.2 million subscribers, Nicholas Jacquart, developer and entrepreneur, moved to South London with a 30-year-old businessman, Chris Evans and set up Ouza Ltd to try his luck with Baby British Bimbos.
Looks like he gauged the market correctly. Recently […]
Posted by H. Sandra Chevalier-Batik
Money and Politics: Illuminating the Connection
MAPLight.org is developing a mashup* that shows a correlation between political campaign contributions and the way lawmakers vote.
During the Watergate scandal that eventually toppled President Richard Nixon, confidential source “Deep Throat” advised two enterprising Washington Post reporters to “follow the money” to uncover the scandal’s ringleaders.
MAPLight.org, a small, not-for-profit company, […]
Category Archives: 
BlogoSquare